NRX Pharmaceuticals, Inc. (NRXP) › Shareholders' EquityNRX Pharmaceuticals, Inc. (NRXP) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2017: $5.00M2018: $5.00M2019: -$4.84M2020: -$43.77M2021: $20.81M2022: $7.41M2023: -$11.73M2024: -$23.22M2025: -$15.94M-$15.94M2017Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025-$15.94M+31.4%2024-$23.22M-97.9%2023-$11.73M-258.4%2022$7.41M-64.4%2021$20.81M+147.5%2020-$43.77M-803.8%2019-$4.84M-196.9%2018$5.00M+0.0%2017$5.00M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share